A. Pros

996 total citations
18 papers, 148 citations indexed

About

A. Pros is a scholar working on Pathology and Forensic Medicine, Rheumatology and Immunology. According to data from OpenAlex, A. Pros has authored 18 papers receiving a total of 148 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 7 papers in Rheumatology and 6 papers in Immunology. Recurrent topics in A. Pros's work include Systemic Lupus Erythematosus Research (6 papers), Systemic Sclerosis and Related Diseases (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). A. Pros is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), Systemic Sclerosis and Related Diseases (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). A. Pros collaborates with scholars based in Spain, Netherlands and United Kingdom. A. Pros's co-authors include Agustí Toll, E. Beltrán, J. Carbonell, Ramón M. Pujol, M. Á. Aguirre, V Fonollosa, M T Camps, Rosa García-Portales, Norberto Ortego‐Centeno and Marieke J. H. Coenen and has published in prestigious journals such as International Journal of Molecular Sciences, Annals of the Rheumatic Diseases and British Journal of Dermatology.

In The Last Decade

A. Pros

17 papers receiving 145 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Pros Spain 6 90 45 39 34 29 18 148
L. P. Ananyeva Russia 6 123 1.4× 60 1.3× 28 0.7× 32 0.9× 31 1.1× 55 177
E. Puzenat France 7 74 0.8× 22 0.5× 44 1.1× 23 0.7× 17 0.6× 19 187
Áurea Canelhas Portugal 8 36 0.4× 24 0.5× 24 0.6× 23 0.7× 31 1.1× 23 356
Avram Goldberg United States 3 51 0.6× 56 1.2× 16 0.4× 42 1.2× 18 0.6× 4 105
J. Sahhar Australia 4 159 1.8× 37 0.8× 32 0.8× 33 1.0× 55 1.9× 8 183
Paolo Airó Italy 4 150 1.7× 85 1.9× 51 1.3× 74 2.2× 82 2.8× 7 214
María Victoria Egurbide Spain 5 97 1.1× 24 0.5× 37 0.9× 46 1.4× 33 1.1× 6 143
Ana Maria Gheorghiu Romania 8 76 0.8× 60 1.3× 53 1.4× 95 2.8× 20 0.7× 20 180
Virginia Mancini Italy 9 62 0.7× 20 0.4× 11 0.3× 44 1.3× 20 0.7× 30 203
Kim Fligelstone United States 4 237 2.6× 35 0.8× 124 3.2× 74 2.2× 67 2.3× 11 257

Countries citing papers authored by A. Pros

Since Specialization
Citations

This map shows the geographic impact of A. Pros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Pros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Pros more than expected).

Fields of papers citing papers by A. Pros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Pros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Pros. The network helps show where A. Pros may publish in the future.

Co-authorship network of co-authors of A. Pros

This figure shows the co-authorship network connecting the top 25 collaborators of A. Pros. A scholar is included among the top collaborators of A. Pros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Pros. A. Pros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tío, Laura, et al.. (2024). Serum Advanced Glycation End Products and Their Soluble Receptor as New Biomarkers in Systemic Lupus Erythematosus. Biomedicines. 12(3). 610–610. 2 indexed citations
2.
Tío, Laura, Carolina Pérez-García, A. Pros, et al.. (2024). Role of Advanced Glycation End Products as New Biomarkers in Systemic Lupus Erythematosus. International Journal of Molecular Sciences. 25(5). 3022–3022. 2 indexed citations
3.
4.
Tío, Laura, et al.. (2023). Left ventricular dysfunction and arrhythmias in asymptomatic patients with systemic sclerosis. Medicina Clínica. 160(10). 434–442. 2 indexed citations
5.
Pérez-García, Carolina, et al.. (2021). Leflunomide: A safe and effective alternative in systemic lupus erythematosus. Autoimmunity Reviews. 21(2). 102960–102960. 6 indexed citations
6.
Pros, A., et al.. (2020). Tocilizumab may induce secondary hypogammaglobulinaemia. A retrospective case series of 42 patients. Joint Bone Spine. 87(5). 503–505. 1 indexed citations
7.
Pros, A., et al.. (2020). The use of tocilizumab in the treatment of refractory eosinophilic fasciitis: a case-based review. Clinical Rheumatology. 39(5). 1693–1698. 12 indexed citations
8.
9.
Pros, A., et al.. (2020). FRI0111 TOCILIZUMAB MAY INDUCE SECONDARY HYPOGAMMAGLOBULINAEMIA. A RETROSPECTIVE CASE SERIES OF 42 PATIENTS. Annals of the Rheumatic Diseases. 79. 636–636. 1 indexed citations
10.
Pros, A., et al.. (2018). Isolated DLco/VA reduction in systemic sclerosis patients: a new patient subset?. Clinical Rheumatology. 37(12). 3365–3371.
11.
Rueda‐Medina, Blanca, Carmen Pilar Simeón‐Aznar, Roger Hesselstrand, et al.. (2008). A large multicenter analysis of CTGF-945 promoter polymorphism does not confirm association with systemic Sclerosis susceptibility or phenotype. Lund University Publications (Lund University). 58(9). 588–589. 1 indexed citations
12.
Herrick, Ariane L., Jane Worthington, Norberto Ortego‐Centeno, et al.. (2008). A large multicentre analysis of CTGF −945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype. Annals of the Rheumatic Diseases. 68(10). 1618–1620. 33 indexed citations
13.
Torres, Orlando, Norberto Ortego‐Centeno, V Fonollosa, et al.. (2008). The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype. Annals of the Rheumatic Diseases. 68(2). 253–256. 33 indexed citations
14.
Beltrán, E., Agustí Toll, A. Pros, J. Carbonell, & Ramón M. Pujol. (2007). Assessment of nailfold capillaroscopy by נ30 digital epiluminescence (dermoscopy) in patients with Raynaud phenomenon. British Journal of Dermatology. 156(5). 892–898. 40 indexed citations
15.
Pros, A.. (2000). Calcificaciones subcutáneas y periostitis en extremidades inferiores en imágenes. 27(4). 137–140. 2 indexed citations
16.
Blanch, Josep & A. Pros. (1999). Calcium as a treatment of osteoporosis. Drugs of today. 35(8). 631–631. 5 indexed citations
17.
Pros, A., et al.. (1998). [Lupus myelitis: value of magnetic resonance].. PubMed. 110(4). 159–159. 2 indexed citations
18.
Blanch, Jordi, et al.. (1997). [Favorable response to corticoid therapy in a patient with transverse myelitis in systemic lupus erythematosus].. PubMed. 14(12). 630–2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. P. Ananyeva Breakdown of academic impact, for papers by E. Puzenat Breakdown of academic impact, for papers by Áurea Canelhas Breakdown of academic impact, for papers by Avram Goldberg Breakdown of academic impact, for papers by J. Sahhar Breakdown of academic impact, for papers by Paolo Airó Breakdown of academic impact, for papers by María Victoria Egurbide Breakdown of academic impact, for papers by Ana Maria Gheorghiu Breakdown of academic impact, for papers by Virginia Mancini Breakdown of academic impact, for papers by Kim Fligelstone
Rankless by CCL
2026